Foundation Medicine
Foundation Medicine's Overview
Foundation Medicine is a world-leading molecular insights company dedicated to transforming cancer care. They achieve this by providing comprehensive genomic profiling (CGP) tests that analyze a patient's tumor DNA to identify unique genomic alterations. These insights help oncologists match patients with relevant targeted therapies, immunotherapies, and clinical trials. Their portfolio includes well-known tests such as FoundationOne®CDx, FoundationOne®Liquid CDx, and FoundationOne®Heme. By decoding the molecular makeup of each patient's cancer, Foundation Medicine aims to empower doctors and patients with the information needed to make informed treatment decisions and accelerate the development of new cancer therapies. The company is a wholly-owned subsidiary of Roche.
Where is Foundation Medicine's Headquarters?
HQ Function
The Cambridge headquarters serves as the central hub for research and development, advanced laboratory operations, data science, bioinformatics, and corporate functions. It drives the company's innovation in cancer genomics and the development of new diagnostic products.
Notable Features:
State-of-the-art CLIA-certified, CAP-accredited, and NYS-CLEP-permitted laboratory facilities for high-throughput genomic sequencing and analysis. Its location in Kendall Square offers proximity to leading academic institutions, research organizations, and other biotech companies, fostering collaboration.
Work Culture:
The work culture at Foundation Medicine's headquarters is characterized by a strong emphasis on science, innovation, collaboration, and a patient-centric mission. Employees are driven by the impact their work has on cancer patients' lives, fostering a dynamic and purpose-driven environment.
HQ Significance:
The Cambridge headquarters is highly significant as it's the birthplace of many of Foundation Medicine's pioneering genomic tests. Its strategic location in a leading biotech ecosystem allows access to top talent and facilitates partnerships critical for advancing precision oncology.
Values Reflected in HQ: The headquarters' design, cutting-edge technology, and location emphasize innovation, scientific rigor, patient impact, and collaboration, reflecting Foundation Medicine's core values of transforming cancer care through deep genomic insights and teamwork.
Location:
Foundation Medicine supports cancer care globally by providing its comprehensive genomic profiling services to oncologists and patients in over 100 countries. This is achieved through direct operations in North America and Europe (e.g., Germany), and through collaborations with local distributors, laboratories, and healthcare providers in other regions including Asia-Pacific, Latin America, and the Middle East. This expansive network aims to make advanced cancer diagnostics accessible worldwide and supports global clinical trials for new oncology therapies.
Street Address:
150 Second Street
City:
Cambridge
State/Province:
MA
Country:
USA
Foundation Medicine's Global Presence
Penzberg, Germany
Address: Foundation Medicine GmbH, Nonnenwald 2, 82377 Penzberg, Germany
To expand access to Foundation Medicine's comprehensive genomic profiling services across the EMEA region, ensuring timely and high-quality diagnostic support for oncologists and fostering collaborations within the European healthcare ecosystem.
Morrisville, NC, USA
Address: 7020 Kit Creek Rd, Morrisville, NC 27560, USA
To enhance the company's national testing capabilities, provide operational redundancy, and tap into the rich life sciences talent pool in the Research Triangle Park area, supporting efficient and scalable diagnostic services across the U.S.
San Diego, CA, USA
Address: 101 Variant R D, San Diego, CA 92121, USA
To leverage Southern California's dynamic biotech cluster, fostering innovation in non-invasive cancer diagnostics and bioinformatics, and to collaborate with local research institutions and partners to advance the field.
Buying Intent Signals for Foundation Medicine
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Foundation Medicine
As of April 2025, Foundation Medicine' leadership includes:
Investors of Foundation Medicine
Foundation Medicine has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
The most significant executive leadership change in the recent period involved the CEO position. In March 2023, Brian Alexander, M.D., M.P.H. was appointed Chief Executive Officer, taking over from Cindy Perettie. Since this key transition, the C-suite team has largely remained consistent, focusing on driving the company's strategic initiatives in precision oncology.
Departures
New Appointments:
Technology (Tech Stack) used by Foundation Medicine
Discover the tools Foundation Medicine uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Foundation Medicine Email Formats and Examples
Foundation Medicine typically uses a standard corporate email format. The most common structure observed is the first initial of the employee's first name followed by their full last name, all preceding '@foundationmedicine.com'. Variations might exist, but this is a widely recognized pattern.
[first_initial][last_name]@foundationmedicine.com
Format
jdoe@foundationmedicine.com
Example
85%
Success rate
News and media
Foundation Medicine Press Release • April 24, 2024
Foundation Medicine Receives FDA Approval for FoundationOne®Liquid CDx to be Used as a Companion Diagnostic for Alpelisib in Men with PIK3CA-Mutated, HR+, HER2- Advanced or Metastatic Breast Cancer
Foundation Medicine announced that the U.S. Food and Drug Administration (FDA) approved FoundationOne®Liquid CDx as a companion diagnostic for alpelisib with fulvestrant for treating men, and postmenopausal women, with HR+, HER2-, PIK3CA-mutated advanced or metastatic breast cancer post-endocrine therapy progression....more
Foundation Medicine Press Release • February 29, 2024
Foundation Medicine and Pfizer Reach Key Milestone to Support Advancement of FoundationCore™, a Centralized Cloud-Based Platform for Tumor Genomic Data
Foundation Medicine and Pfizer Inc. announced a key development milestone in their collaboration to develop FoundationCore™, a consolidated cloud-based data platform designed to enhance how genomic data from Foundation Medicine's tests can be accessed and utilized by researchers and clinicians to accelerate drug development and improve patient care....more
Foundation Medicine Press Release • January 8, 2024
Foundation Medicine Empowers Oncologists with New Tools and Enhanced Report Features to Help Guide More Informed Treatment Decisions
Foundation Medicine announced new features for its comprehensive genomic profiling (CGP) test reports, including an AI-enabled tool to streamline information and improved clinical trial matching. These enhancements aim to provide oncologists with clearer, more actionable insights to personalize cancer treatment....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Foundation Medicine, are just a search away.